Nuclera, a biotechnology company enabling rapid protein expression and purification screening through its benchtop protein platform, has appointed William J Kullback as a non-executive director.
TechnologyPermira: Jon Serbousek

Private equity firm Permira has appointed Jon Serbousek as a senior advisor to its global healthcare team.
Serbousek has more than 35 years’ experience in the healthcare sector, including international leadership roles in medical technology companies. Most recently Serbousek led Orthofix Medical as its president and chief executive, and until recently as executive chairman of the newly merged Orthofix-SeaSpine. His previous roles include worldwide group president of Biomet Orthopedics, worldwide president of Biomet Biologics, division president for Medtronic Spine and Biologics, and vice-president of marketing and product development for DePuy Orthopedics, a Johnson & Johnson medical device and biologics company. Serbousek has also sat on numerous boards, both for-profit and non-profit.
Silvia Oteri, partner and head of healthcare at Permira, said: “[Serbousek’s] broad experience, strategic acumen, and deep knowledge of the medtech space will be invaluable as we continue to build and expand our investments in the healthcare sector.”
Serbousek commented: “I’m excited to join Permira, a firm known for its deep understanding of healthcare and commitment to long-term value creation. I look forward to leveraging my experience to support the healthcare team and help drive growth and innovation for Permira’s portfolio companies and stakeholders.”
Permira has investments in approximately 20 healthcare companies globally, deploying more than €4 billion. It employs over 500 people in 15 offices across Europe, the US and Asia.
Latest Executive Moves
Cambridge Cognition, which provides cognitive assessment software for clinical trials, academic research and healthcare, has appointed Jonathan Kempster as an independent non-executive director.
TechnologyStax has appointed Adam Thorpe as a managing director in its London office to lead the firm’s EMEA healthcare vertical.